James Boylan
Directeur/Membre du Conseil chez COMPASS THERAPEUTICS, INC.
Fortune : - $ au 30/06/2024
Profil
Mr. James P.
Boylan is an Independent Director at Immunome, Inc., an Independent Director at Compass Therapeutics, Inc. and a Chief Executive Officer & Director at Enavate Sciences.
He is on the Board of Directors at Immunome, Inc., Compass Therapeutics, Inc., Enavate Sciences, Camp4 Therapeutics Corp.
and Zenas Pharma, Inc. Mr. Boylan was previously employed as a President & Head-Investment Banking by SVB Securities LLC, a President & Head-Investment by SVB Leerink Holdings LLC, and a Managing Director by Merrill Lynch & Co., Inc. /Old/.
He received his undergraduate degree from Lehigh University and an MBA from Columbia Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 0 ( -.--% ) | - $ | 30/06/2024 | |
IMMUNOME, INC.
-.--% | 13/06/2024 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de James Boylan
| Sociétés | Poste | Début |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2022 |
| IMMUNOME, INC. | Directeur/Membre du Conseil | 02/10/2023 |
Enavate Sciences
 Enavate Sciences Financial ConglomeratesFinance Enavate Sciences is a platform created by Patient Square Capital that supports therapeutic companies advancing medicines and enabling technologies to address patient needs. Enavate Sciences is based in New York, NY. The company provides capital support and operational experience to a diverse portfolio of therapeutics companies, aiming to accelerate innovation. James P. Boylan has been the CEO of the company since 2022. | Directeur Général | 01/05/2022 |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Directeur/Membre du Conseil | - |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de James Boylan
| Sociétés | Poste | Fin |
|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | President | 01/04/2021 |
SVB Securities Holdings LLC
 SVB Securities Holdings LLC Financial ConglomeratesFinance SVB Leerink Holdings LLC operates as an investment bank holding company with interest in investment services. The firm provides equity research, institutional sales and trading, corporate finance and strategic advisory services. The company was founded in 1995 and is headquartered in Boston, MA. | President | 01/04/2021 |
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Corporate Officer/Principal | 01/05/2009 |
Formation de James Boylan
| Lehigh University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| COMPASS THERAPEUTICS, INC. | Health Technology |
| IMMUNOME, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Finance |
Enavate Sciences
Enavate Sciences Financial ConglomeratesFinance Enavate Sciences is a platform created by Patient Square Capital that supports therapeutic companies advancing medicines and enabling technologies to address patient needs. Enavate Sciences is based in New York, NY. The company provides capital support and operational experience to a diverse portfolio of therapeutics companies, aiming to accelerate innovation. James P. Boylan has been the CEO of the company since 2022. | Finance |
SVB Securities Holdings LLC
SVB Securities Holdings LLC Financial ConglomeratesFinance SVB Leerink Holdings LLC operates as an investment bank holding company with interest in investment services. The firm provides equity research, institutional sales and trading, corporate finance and strategic advisory services. The company was founded in 1995 and is headquartered in Boston, MA. | Finance |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
Zenas Pharma, Inc.
Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Health Technology |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
